Skip to content
healthcare.dev

Naprelan

NDC 52427-272, Naproxen Sodium, tablet, film coated, extended release, from Almatica Pharma LLC.

Product NDC
52427-272
Status
Listed
Labeler
Almatica Pharma LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52427-272 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM375 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
52427-272-0152427027201100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-272-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e633ff0b-eab7-f167-8d08-e9236e54042b

Use it

Look up 52427-272 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52427-272 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52427-272. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.